A Phase II Study of Lenalidomide for Adult Histiocyte Disorders
Latest Information Update: 29 Apr 2025
At a glance
- Drugs Lenalidomide (Primary)
- Indications Erdheim-Chester disease; Langerhans cell histiocytosis; Sarcoma
- Focus Therapeutic Use
Most Recent Events
- 18 Dec 2024 Planned End Date changed from 1 Aug 2024 to 1 Aug 2025.
- 14 Feb 2024 Planned End Date changed from 1 Sep 2024 to 1 Aug 2024.
- 15 Jun 2023 Planned End Date changed from 1 Sep 2023 to 1 Sep 2024.